191 related articles for article (PubMed ID: 8870815)
1. Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.
Wasner HK; Lessmann M; Conrad M; Amini H; Psarakis E; Mir-Mohammad-Sadegh A
Acta Diabetol; 1996 Jul; 33(2):126-38. PubMed ID: 8870815
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, a result of reduced synthesis of prostaglandylinositol cyclic phosphate, a mediator of insulin action? Regulation of cyclic PIP synthetase activity by oral antidiabetic and antihypertensive drugs.
Wasner HK; Salge U; Psarakis E; Niktopoulos A
Acta Diabetol; 1997 Dec; 34(4):257-64. PubMed ID: 9451469
[TBL] [Abstract][Full Text] [Related]
3. The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate.
Wasner HK; Salge U; Gebel M
Acta Diabetol; 1993; 30(4):220-32. PubMed ID: 8180414
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and action of the cyclic AMP antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), in Dictyostelium discoideum.
Kaiser AM; Wasner HK; Spindler KD
Biol Chem; 1998 Jun; 379(6):727-30. PubMed ID: 9687023
[TBL] [Abstract][Full Text] [Related]
5. Two different mechanisms for activation of cyclic PIP synthase: by a G protein or by protein tyrosine phosphorylation.
Wasner HK; Gebel M; Hucken S; Schaefer M; Kincses M
Biol Chem; 2000 Feb; 381(2):145-53. PubMed ID: 10746746
[TBL] [Abstract][Full Text] [Related]
6. Activated Inositol Phosphate, Substrate for Synthesis of Prostaglandylinositol Cyclic Phosphate (Cyclic PIP)-The Key for the Effectiveness of Inositol-Feeding.
Gypakis A; Adelt S; Lemoine H; Vogel G; Wasner HK
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338641
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandylinositol cyclic phosphate, an antagonist to cyclic AMP.
Wasner HK; Salge U
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():691-5. PubMed ID: 2823565
[TBL] [Abstract][Full Text] [Related]
8. Degradation of the cyclic AMP antagonist prostaglandylinositol cyclic phosphate (cyclic PIP) by dephosphorylation.
Kassner A; Lessmann M; Wasner HK
Biol Chem; 1999 Jan; 380(1):85-8. PubMed ID: 10064141
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandylinositol cyclic phosphate, the natural antagonist of cyclic AMP.
Wasner HK
IUBMB Life; 2020 Nov; 72(11):2282-2289. PubMed ID: 32893983
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action.
Wasner HK; Weber S; Partke HJ; Amini-Hadi-Kiashar H
Acta Diabetol; 1994 Dec; 31(4):175-82. PubMed ID: 7888687
[TBL] [Abstract][Full Text] [Related]
11. Metformin's Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP).
Wasner HK
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216316
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase and prostaglandylinositol cyclic phosphate (cyclic PIP), a mediator of insulin action, in the signal transduction of insulin.
Gypakis A; Wasner HK
Biol Chem; 2000 Nov; 381(11):1139-41. PubMed ID: 11154073
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger of insulin action. Comparative analysis of two kinds of "insulin mediators".
Shashkin PN; Wasner HK; Ortmeyer HK; Hansen BC
Diabetes Metab Res Rev; 2001; 17(4):273-84. PubMed ID: 11544611
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of inositol phosphoglycan with prostaglandylinositol cyclic phosphate, two potential mediators of insulin action.
Wasner HK; Müller G; Eckel J
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):358-63. PubMed ID: 14520603
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel isomer of myo-inositol tetrakisphosphate.
Shears SB; Parry JB; Tang EK; Irvine RF; Michell RH; Kirk CJ
Biochem J; 1987 Aug; 246(1):139-47. PubMed ID: 2823793
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin deficiency promotes sensitization of adenylyl cyclase.
Weber S; Lemoine H; Wasner HK
Biol Chem; 2000; 381(5-6):525-9. PubMed ID: 10937886
[TBL] [Abstract][Full Text] [Related]
17. Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex.
Godfrey PP; McClue SJ; White AM; Wood AJ; Grahame-Smith DG
J Neurochem; 1989 Feb; 52(2):498-506. PubMed ID: 2536074
[TBL] [Abstract][Full Text] [Related]
18. Adenosine triphosphate activates the phospholipase-C cascade system in human amnion cells without increasing prostaglandin production.
Vander Kooy D; Dubyak GR; Moore RM; Moore JJ
Endocrinology; 1989 Apr; 124(4):2005-12. PubMed ID: 2924732
[TBL] [Abstract][Full Text] [Related]
19. Adenosine and neuropeptide Y enhance alpha 1-adrenoceptor-induced accumulation of inositol phosphates and attenuate forskolin-induced accumulation of cyclic AMP in rat vas deferens.
Häggblad J; Fredholm BB
Neurosci Lett; 1987 Nov; 82(2):211-6. PubMed ID: 2827073
[TBL] [Abstract][Full Text] [Related]
20. Glycerol-3-phospho-D-myo-inositol 4-phosphate (Gro-PIP) is an inhibitor of phosphoinositide-specific phospholipase C.
Cruz-Rivera M; Bennett CF; Crooke ST
Biochim Biophys Acta; 1990 Jan; 1042(1):113-8. PubMed ID: 2153409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
